ft.com
>
Companies
>
Health
>
Healthcare
News
Quotes
News
Quotes
Search
Advanced search
Sign in
Site tour
Register
Subscribe
Welcome
Your account
Site tour
Sign out
Username
Password
Forgot password?
Remember me on this computer
Sign in
Home
Video
Interactive
Blogs
Alphaville
beyondbrics
Portfolio
Special Reports
In depth
Today’s Newspaper
World
Africa
Asia-Pacific
Asia-Pacific
China
India
Japan
Afghanistan
Pakistan
Europe
Europe
Brussels
Latin America & Caribbean
Latin America & Caribbean
Business
Economy
Finance
Politics & Policy
Regulation
Society
Middle East & North Africa
Middle East & North Africa
Economy
Finance
Politics & Society
Iran
Iraq
Arab-Israel conflict
UK
UK
Business
Economy
UK Companies
Politics & Policy
UK Small Companies
US & Canada
US & Canada
Economy
Politics & Policy
Society
Canada
The World blog
Companies
Energy
Energy
Mining
Oil & Gas
Utilities
Financials
Financials
Banks
Insurance
Property
Financial Services
Health
Health
Health Care
Pharmaceuticals
Industrials
Industrials
Aerospace & Defence
Automobiles
Basic Resources
Chemicals
Construction
Industrial Goods
Luxury 360
Media
Retail & Consumer
Retail & Consumer
Food & Beverage
Personal & Household Goods
Retail
Travel & Leisure
Tech
Tech
Science
Telecoms
Transport
Transport
Airlines
Shipping
Rail
By Region
By Region
US Companies
UK Companies
European Companies
Americas Companies
Asia-Pacific Companies
African Companies
Middle Eastern Companies
UK Small Companies
Tools
Tools
Portfolio
FT clippings
Alerts hub
Email briefings
MBA rankings
FT Lexicon
Mobile
Currency converter
ePaper
FT press cuttings
Privilege Club
Social Media hub
Economic calendar
Companies A-Z
FT30
FT 500
Companies Week Ahead
Companies Week in Review
Markets
Alphaville
FTfm
FTfm
Regulation
ETFs
Investment Strategy
Pensions
People
Video
Markets Data
Markets Data
Bonds & Rates
Commodities
Funds
Director Deals
ETFs
Companies
Currencies
Investor Relations
Equity Indices
Interactive Charting
Data Archive
Portfolio
Economic Calendar
Trading Room
Trading Room
Clearing & Settlement
Developing Markets & Asia
Markets Regulation
Trading Technology
Quick View
Carbon Markets
Exchanges Consolidation
Equities
Equities
US
UK
Europe
Asia-Pacific
Currencies
Capital Mkts
Commodities
Emerging Mkts / beyondbrics
Global Economy
Economic Calendar
Money Supply
Americas
China
EU
India
Middle East
UK
US
Lex
About Lex
Best of Lex
Lex on Mobile
Lex by Email
Lex Video
Lexicon
Subscribe to Lex
Comment
Columnists
Columnists
Samuel Brittan
Christopher Caldwell
John Gapper
Brian Groom
John Kay
James Kynge
Edward Luce
Jurek Martin
Wolfgang Munchau
David Pilling
Ingram Pinn
Robert Pozen
Gideon Rachman
Robert Shrimsley
Gary Silverman
Philip Stephens
Gillian Tett
Martin Wolf
Analysis
Opinion
The A-List
Editorial
Blogs
Blogs
beyondbrics
Brussels Blog
Business Blog
Economists’ Forum
FT Alphaville
FT Tech hub
Gavyn Davies
Martin Wolf’s Exchange
Material World
MBA Blog
Money Supply
The World
Westminster Blog
Letters
Corrections
Obituaries
Management
Business Education
Business Education
All Rankings
MBA
Masters in Management
EMBA
Business School News
Women at Business School
Entrepreneurship
Business Books
Business Travel
Recruitment
The Connected Business
Women at the Top
Life & Arts
Arts
Arts
Collecting
Design & Architecture
Film & Television
Music
Theatre & Dance
Visual Arts
FT Magazine
Food & Drink
House & Home
Style
Books
Books
Essay
Fiction
Non-Fiction
Pursuits
Pursuits
Crossword
Sudoku
Travel
Travel
UK
North America
Europe
Asia & Australia
Africa
Americas
Luxury
Adventures
Winter Sports
Family
City Breaks
How To Spend It
Christmas 2011
Highlights
beyondbrics
Accountancy column
Luxury 360
FT Trading Room
Lombard
Business blog
Tech hub
From
PHARMACEUTICALS
Dec 27, 2011
Shire in warning on drug pricing
Move comes amid pressure on healthcare budgets
The day a drug company boss saw the light
ChiMed unveils global deal with AstraZeneca
J&J; opts out of HIV rights sharing pool
Debate grows over regulation of implants
Dec 23, 2011
Khazanah buys 75% of Turkish hospital chain
Wealth fund begins Mideast expansion
Beyondbrics – Turkey
“unstoppable” for long?
In depth
M&A;
Dec 22, 2011
Thomson Reuters suspends healthcare arm sale
Company blames challenging global economy
In depth
M&A;
Collapse in M&A; amid debt turbulence
Dec 16, 2011
Covidien to spin off drugs business
US group to focus on medical devices
Amgen chief executive to retire
GE Healthcare in ‘low-cost’ factories tie-up
From
WORLD
Dec 14, 2011
NHS trusts face funding squeeze
Spending to rise just 0.1 per cent in real terms
Postcode lottery for NHS treatment
Comment
Debate looms about how to fund the NHS
From
MANAGEMENT
Dec 14, 2011
Charity begins at the office
Corporate links to non-profits are becoming more sophisticated
FT seasonal appeal 2011
A new kind of benevolence
Dec 14, 2011
Southern Cross hands over last of care homes
Move follows difficulties rearranging finances
Minister refused Southern Cross crisis talks
Southern Cross hands over 35 homes
From
TECHNOLOGY
Dec 13, 2011
Olympus accounts deadline exposes auditors
Accountants under pressure to sign off revised statements
Olympus pledges legal action after report
Lex
Olympus
From
WORLD
Dec 8, 2011
Private health faces competition probe
Market criticised over lack of consumer information
Office of Fair Trading statement
Lansley unveils rate-your-NHS indicators
From
PHARMACEUTICALS
Dec 8, 2011
Sinclair IS Pharma buys Kelo-cote for £16.7m
Scar gel purchase from Advanced Bio-Technologies boosts share price
Lex
Daiichi Sankyo - bad medicine
On London
Big pharma outperforms
Dec 8, 2011
UK private healthcare market faces investigation
OFT refers £5bn-a-year industry to competition authorities
From
WORLD
Dec 7, 2011
Lansley unveils rate-your-NHS indicators
Minister accused of piling pressure on overstretched service
From
LEX
Dec 5, 2011
Mediscare: bitter pill for device makers
Manufacturers should tremble when the government threatens to tighten the leash
Dec 5, 2011
US healthcare stocks hit by Medicare fears
Concern over possible limits on expensive procedures
From
RETAIL & CONSUMER
Dec 5, 2011
Fujifilm to launch skincare range in Europe
Japanese group brushes off fears over a eurozone meltdown
From
COMPANIES BY REGION
Dec 2, 2011
AMS to buy German woundcare specialist
€63.8m cash deal for Resorba
From
WORLD
Dec 1, 2011
Charity prevents blindness in Pakistan
Sightsavers provided Ibad ur-Rehman with a life-changing eye operation
Dec 1, 2011
Consort Medical receives boost from inhalers
Pre-tax profit rises by more than 20%
From
COMMENT
Nov 30, 2011
A realm fit for a tsar
From
WORLD
Nov 27, 2011
NHS favoured big kidney dialysis bidders
Concerns that smaller companies were put at disadvantage
Nov 23, 2011
Strong China demand boosts Halma
Safety devices supplier posts 17% rise in pre-tax profits
From
PHARMACEUTICALS
Nov 22, 2011
Merck to pay $950m in Vioxx settlement
Drug company accused of making false claims
From
LEX
Nov 22, 2011
Medtronic: what the doctor ordered
Emerging markets, a 10th of the company’s sales, offer growth. This will take time
From
TECHNOLOGY
Nov 13, 2011
Olympus urged to bring back chief
Former director in campaign to reinstate Woodford
From
TECHNOLOGY
Nov 11, 2011
Olympus takes traditional route to apology
New president Shuichi Takayama bows deeply
From
WORLD
Nov 10, 2011
Private company in NHS hospital takeover
Circle Healthcare set to manage debt-laden Hinchingbrooke
From
COMPANIES BY REGION
Oct 13, 2011
Profit warning hits Renishaw shares
Engineering group to review lossmaking healthcare business
Multimedia
SPECIAL REPORTS
Egyptian healthcare has been starved of resources for years, making it hard to extend decent medical services to the poor
LEX
Directors of drugmaker Daiichi Sankyo decide to return part of their salaries following a wretched deal that acquired Ranbaxy
LEX
Agence,France-Presse
Despite AstraZeneca’s losses, investors should stay as long as the UK-based drugmaker maintains its R&D budget
More stories
Energy
US court blocks new emissions rules
Vialogy in data analysis software push
Data Watch
Russia fights fire on nuclear submarine
Financials
Private equity looks to asset-backed loans
CDR pleads guilty in bid-rigging probe
Corporate figures dominate honours list
SocGen unit to stay away from China IPOs
Industrials
More funds sue Porsche over VW short squeeze
Russia fights fire on nuclear submarine
Spain’s king and queen snubbed royal nuptials
Qatar Holding becomes top Lagardère investor
Telecoms
Deutsche Telekom settles bribery case
RIM suffers annus horribilis
Ambani matriarch says family is ‘united’
France Telecom to sell Swiss unit to Apax
Technology
RIM suffers annus horribilis
Apple seeks renewal after death of Jobs
Spring showdown looms for Olympus
Former HP chief loses appeal over letter
Markets
Shares suffer first annual loss since 2008
$6.3tn wiped off markets in 2011
Forex traders hunt for fresh havens
Tumultuous year ends with few rewards for risk-takers
Offers
EXEC-APPOINTMENTS.COM
Global executive jobs
Register today for free job alerts
JOIN THE BUSINESS ELITE
More people at the top read the FT*
*FT has grown in every major readership survey in 2010
FT SUBSCRIPTION
Subscribe today!
Save and get FREE delivery
Companies videos
You need JavaScript active on your browser in order see this video.
Editor's Choice
Lunch with the FT
Peter Brant, the industrialist, reveals why he identifies with the 99%
financials
Experts give their predictions for the 2012 M&A market
In depth
UBS trading scandal
Bank bonuses
Initial public offerings
Tax wars
Phone-hacking scandal
More in depth
Highlights
Most popular in Companies
Apple in race to keep ahead in 2012
Fed seeks to curb repo market risk
Land prices surge in US shale oilfields
Google challenges Facebook with TV ads
Alibaba hires lobbyist amid Yahoo bid talk
exec-appointments.com
Enter job search
Search
Head of HR, North West
NHS Foundation Trust
Senior Electrical Engineer
CERN
Head of Human Resources
International research organisation
Finance Manager
IT Services
Register for free to receive the latest executive jobs by email
Multimedia
Video
Blogs
Podcasts
Interactive graphics
Audio slideshows
Picture slideshows
Tools
Portfolio
FT Lexicon
FT clippings
Currency converter
MBA rankings
Today's newspaper
FT press cuttings
FT ePaper
Economic calendar
Updates
Alerts Hub
Daily briefings
FT on your mobile
Share prices on your phone
Twitter feeds
RSS feeds
Quick links
Mergermarket
How to spend it
SchemeXpert.com
Social Media hub
The Banker
fDi Intelligence
Professional Wealth Management
This is Africa
Investors Chronicle
MandateWire
Services
Subscriptions
Corporate subscriptions
Syndication
Privilege Club
Conferences
Annual reports
Executive job search
Non-Executive Directors' Club
Businesses for sale
Contracts & tenders
Analyst research
Company announcements
Mediscare: bitter pill for device makers
Manufacturers should tremble when the government threatens to tighten the leash